![The connection between a new class of weight loss drugs and cancer risk reduction – MSKCC](https://oncodaily.com/pub/uploads/2024/08/Screenshot-2024-09-02-at-01.39.42-e1725221423817-1280x629.png)
Collage of Diane Reidy-Lagunes and Neil Iyengar
Sep 2, 2024, 07:00
The connection between a new class of weight loss drugs and cancer risk reduction – MSKCC
Memorial Sloan Kettering Cancer Center shared a post on X:
“In this episode of Cancer Straight Talk, Diane Reidy-Lagunes sits down with MSK’s Neil Iyengar to discuss the intriguing connection between a new class of weight loss drugs, called GLP-1 agonists, and cancer risk reduction.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023